207 related articles for article (PubMed ID: 38625936)
1. APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation.
Lorenzo JP; Molla L; Amro EM; Ibarra IL; Ruf S; Neber C; Gkougkousis C; Ridani J; Subramani PG; Boulais J; Harjanto D; Vonica A; Di Noia JM; Dieterich C; Zaugg JB; Papavasiliou FN
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2312330121. PubMed ID: 38625936
[TBL] [Abstract][Full Text] [Related]
2. Zinc-binding domain-dependent, deaminase-independent actions of apolipoprotein B mRNA-editing enzyme, catalytic polypeptide 2 (Apobec2), mediate its effect on zebrafish retina regeneration.
Powell C; Cornblath E; Goldman D
J Biol Chem; 2014 Oct; 289(42):28924-41. PubMed ID: 25190811
[TBL] [Abstract][Full Text] [Related]
3. APOBEC2 negatively regulates myoblast differentiation in muscle regeneration.
Ohtsubo H; Sato Y; Suzuki T; Mizunoya W; Nakamura M; Tatsumi R; Ikeuchi Y
Int J Biochem Cell Biol; 2017 Apr; 85():91-101. PubMed ID: 28215905
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy.
Sato Y; Probst HC; Tatsumi R; Ikeuchi Y; Neuberger MS; Rada C
J Biol Chem; 2010 Mar; 285(10):7111-8. PubMed ID: 20022958
[TBL] [Abstract][Full Text] [Related]
5. Excessive activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide 2 (APOBEC2) contributes to liver and lung tumorigenesis.
Okuyama S; Marusawa H; Matsumoto T; Ueda Y; Matsumoto Y; Endo Y; Takai A; Chiba T
Int J Cancer; 2012 Mar; 130(6):1294-301. PubMed ID: 21469143
[TBL] [Abstract][Full Text] [Related]
6. APOBEC2 mRNA and protein is predominantly expressed in skeletal and cardiac muscles of chickens.
Li J; Zhao XL; Gilbert ER; Li DY; Liu YP; Wang Y; Zhu Q; Wang YG; Chen Y; Tian K
Gene; 2014 Apr; 539(2):263-9. PubMed ID: 24440786
[TBL] [Abstract][Full Text] [Related]
7. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
[TBL] [Abstract][Full Text] [Related]
8. Apobec2 deficiency causes mitochondrial defects and mitophagy in skeletal muscle.
Sato Y; Ohtsubo H; Nihei N; Kaneko T; Sato Y; Adachi SI; Kondo S; Nakamura M; Mizunoya W; Iida H; Tatsumi R; Rada C; Yoshizawa F
FASEB J; 2018 Mar; 32(3):1428-1439. PubMed ID: 29127187
[TBL] [Abstract][Full Text] [Related]
9. Mice deficient in APOBEC2 and APOBEC3.
Mikl MC; Watt IN; Lu M; Reik W; Davies SL; Neuberger MS; Rada C
Mol Cell Biol; 2005 Aug; 25(16):7270-7. PubMed ID: 16055735
[TBL] [Abstract][Full Text] [Related]
10. Expression of APOBEC2 is transcriptionally regulated by NF-kappaB in human hepatocytes.
Matsumoto T; Marusawa H; Endo Y; Ueda Y; Matsumoto Y; Chiba T
FEBS Lett; 2006 Feb; 580(3):731-5. PubMed ID: 16427049
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
MacGinnitie AJ; Anant S; Davidson NO
J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
[TBL] [Abstract][Full Text] [Related]
13. Modulating APOBEC expression enhances DNA vaccine immunogenicity.
Almeida RR; Raposo RA; Coirada FC; da Silva JR; de Souza Ferreira LC; Kalil J; Nixon DF; Cunha-Neto E
Immunol Cell Biol; 2015 Nov; 93(10):868-76. PubMed ID: 25953029
[TBL] [Abstract][Full Text] [Related]
14. APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis.
Rogozin IB; Basu MK; Jordan IK; Pavlov YI; Koonin EV
Cell Cycle; 2005 Sep; 4(9):1281-5. PubMed ID: 16082223
[TBL] [Abstract][Full Text] [Related]
15. The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.
Prohaska KM; Bennett RP; Salter JD; Smith HC
Wiley Interdiscip Rev RNA; 2014; 5(4):493-508. PubMed ID: 24664896
[TBL] [Abstract][Full Text] [Related]
16. An overview of cytidine deaminases.
Navaratnam N; Sarwar R
Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
[TBL] [Abstract][Full Text] [Related]
17. The APOBEC-2 crystal structure and functional implications for the deaminase AID.
Prochnow C; Bransteitter R; Klein MG; Goodman MF; Chen XS
Nature; 2007 Jan; 445(7126):447-51. PubMed ID: 17187054
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
[TBL] [Abstract][Full Text] [Related]
19. Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands.
Salter JD; Smith HC
Trends Biochem Sci; 2018 Aug; 43(8):606-622. PubMed ID: 29803538
[TBL] [Abstract][Full Text] [Related]
20. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
